Genius Sports offers technology infrastructure for the collection, integration and distribution of live data of sports leagues; streaming solutions, comprising of technology, automatic production and distribution for sports to commercialize video footage of their games; and end-to-end integrity services to sports leagues, such as full-time active monitoring technology, which uses mathematical algorithms to identify and flag suspicious betting activity in global betting markets, as well as full suite of online and offline educational and consultancy services.
Genius Sports also provides live sports data collection; pre-game and in-game odds feeds; risk management services, including customer profiling, monitoring of incoming bets, automated acceptance and rejection of bets, and limit setting; live streaming services; creation, delivery and measurement services for personalized online marketing campaigns; and fan engagement widgets for digital publishers that offer live game statistics and betting-related content.
Genius Sports has an $8 price objective at Credit Suisse. The consensus target is $7, and shares traded at $5.80 on Friday.
908 Devices
This is another Cathie Wood portfolio stock that also has the potential to be a huge winner. 908 Devices Inc. (NASDAQ: MASS) provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics and adjacent markets. It operates in the Americas, Europe, the Middle East, Africa and the Asia Pacific.
The company’s products include:
- MX908, a handheld, battery-powered and Mass Spec device that is designed for rapid analysis of gas, liquid and solid materials of unknown identity
- Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses
- Maven and Trace C2, an online device for bioprocess monitoring and control
- ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis.
The $20 SVB Leerink target price compares with a $17 consensus target. On Friday, 908 Devices stock traded at $8.5o a share.
Cathie Wood’s investments always stir up interest and, after a dreadful 2022, all of her funds have continued to grab investors’ dollars. While they are not for the timid, for those investing for the future and a wide-open tomorrow, she may be just the person to get some outstanding stock ideas from.
Originally published at 24/7 Wall St.
Sponsored: Find a Qualified Financial Advisor
Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.
